News Wearable troponin-I sensor aids in heart attack diagnosis Real-world study finds the device predicts a heart attack with 90% accuracy in five minutes.
News Merck’s cardiovascular pipeline delivers at ACC Data on sotatercept in PAH and oral PCSK9 MK-0616 boost Merck's hopes for the franchise.
News Incyte halts ph3 myelofibrosis study, unmet endpoint Incyte has made it clear that the recommendation to stop the study was not due to safety.
News Nexletol shows CLEAR benefit in cardiovascular outcome trial Will a 13% improvement in MACE over placebo be enough to lift lacklustre sales growth?
News Moderna picks Oxfordshire for UK facility Moderna selects Harwell in Oxfordshire for its new UK facility, next door to the UKHSA.
News FDA said no to trials of Elon Musk’s Neuralink chip; report Regulator has numerous concerns about the implantable device's safety, according to Reuters.
News Pharvaris plans filings for HAE drug after pivotal trial win Pharvaris has reported positive data from a phase 3 trial of its drug for preventing HAE attacks, setting up marketing applications next year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
